You are Trying to View a Free Article
Daily News You Can't Find Anywhere ElseIndia's CSIR, Mylan Make to Collaborate on COVID-19 Therapies, an Industrial Info Market Brief
Industry Segment: Market Brief | Word Count: 156 Words
Attachment: Mylan
The Council of Scientific & Industrial Research (CSIR), India's premier research organization, and Mylan Laboratories Limited, the India-based subsidiary of global pharma giant Mylan, on Thursday announced a partnership to address unmet patient needs amidst the evolving COVID-19 pandemic.
Subscribe Now! All Fields Required...
Related Articles
- J&J launches Largest COVID-19, Single-Shot Vaccine Phase 3 Clinical Trials,...
- SAMREF Plans Upgrade Project to Further Process Heavy Residue, an Industria...
- Nigeria's Largest Oil Refinery Commissioning Delayed, an Industrial Info Ma...
- Iran's Crude Steel Production to Hit 55 Million Tons by 2025, an Industrial...
- COVID Slows Capex in India's Chemical Processing Industry by 14%, an Indust...
- Current Economic Indicators
- Free Daily Industrial Articles
- Monthly Industrial Newsletter
- IIR's Disaster Impact Tracker
All Members Receive the Following Free Resources:
Quick Links
- Home
- About Us
- Contact Us
- For Traders
Global Market Intelligence
- GMI Database Platform
- GMI Platform Tools
- Industry Coverage
- Analytics & Insights
- Advertising
